EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Open Access · CC BY 4.0

Optimized Detection of Left Ventricular Hyperpolarized [1‐ 13 C]Pyruvate Signal in Human Cardiac Metabolic Imaging

Fatemeh Khashami iD, Ivan E Dimitrov, Maximilian Fuetterer iD, Stefan Glöggler iD, Bei Zhang iD, Egzona Tan, Sebastian Kozerke iD, Anke Henning iD, Tarique Hussain iD, Craig R Malloy iD, Nisha Unni iD, Vlad G Zaha iD und 1 weitere

Magnetic Resonance in Medicine · 2026-07 · 96 (1) · 420-434

DOI: 10.1002/mrm.70332 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Magnetic Resonance in Medicine, online erschienen am 06.03.2026. Verfasst von Fatemeh Khashami und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Hauptthemen laut MEDLINE: Heart Ventricles, Magnetic Resonance Imaging, Pyruvic Acid. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, Cancer Prevention and Research Institute of Texas, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to improve the analysis of the left ventricular (LV) blood pool hyperpolarized [1‐ 13 C]pyruvate signal for a more reliable quantification of downstream metabolic outcome.

Methods

Hyperpolarized [1‐ 13 C]pyruvate magnetic resonance spectroscopic images were acquired dynamically at 3 Tesla in 106 participants (NCT03685175). An exponential model was fitted to the distribution of summed LV blood pool [1‐ 13 C]pyruvate signal intensities from all dynamic frames to extract a characteristic numerical fitting value. A threshold formula was introduced to detect a suitable region of interest in the blood pool. A correlation‐based analysis between the LV blood pool [1‐ 13 C]pyruvate signal and the metabolic outcome, i.e., combined myocardial [1‐ 13 C]lactate and [ 13 C]bicarbonate signals, was performed to determine an optimal threshold and was compared to conventional peak‐intensity and percentile‐based approaches.

Results

The exponential numerical fitting value (0.0105 ± 0.0036) of [1‐ 13 C]pyruvate signal intensity distribution was normalized to the area under the curve of the average signal‐to‐noise ratio. A threshold range of 13%–25% was identified where the resulting values representative for the LV blood pool [1‐ 13 C]pyruvate signal reached an optimal correlation with the metabolic outcome. The proposed model showed a more stable correlation between LV blood pool [1‐ 13 C]pyruvate signal and the metabolic outcome compared to conventional peak‐intensity and percentile‐based approaches.

Conclusions

A mathematical model using exponential fitting and thresholding of the intensity distribution of [1‐ 13 C]pyruvate signal in the LV blood pool provides a strong correlation with the metabolic outcome, allowing for a semiautomated method to robustly assess the left ventricular pyruvate signal in dynamic nuclear polarization studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart VentriclesMagnetic Resonance ImagingPyruvic AcidAdultFemaleHumansMaleMiddle AgedAlgorithmsCarbon IsotopesImage Processing, Computer-AssistedMagnetic Resonance SpectroscopyMyocardiumSignal-To-Noise Ratio

Stichwörter der Autor:innen

carbon‐13 magnetic resonance spectroscopygated blood pool imagingleft ventricular blood pool detectionmathematical model

Substanzen

Carbon IsotopesPyruvic Acid

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Philips, Cambridge, Massachusetts, USA.
  • Institute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland.
  • Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Dallas VA Medical Center, Dallas, Texas, USA.

ORCID-Profile: Fatemeh Khashami, Maximilian Fuetterer, Stefan Glöggler, Bei Zhang, Sebastian Kozerke, Anke Henning, Tarique Hussain, Craig R Malloy, Nisha Unni, Vlad G Zaha

Förderung

  • NCATS NIH HHS
  • Cancer Prevention and Research Institute of Texas
  • National Center for Advancing Translational Sciences

Zitieren

APA

Khashami, F., Dimitrov, I. E., Fuetterer, M., Glöggler, S., Zhang, B., Tan, E., Kozerke, S., Henning, A., Hussain, T., Malloy, C. R., Unni, N., Zaha, V. G., & CTOX Trial Investigator(s) (2026). Optimized Detection of Left Ventricular Hyperpolarized [1‐ 13 C]Pyruvate Signal in Human Cardiac Metabolic Imaging. Magnetic Resonance in Medicine, 96(1), 420-434. https://doi.org/10.1002/mrm.70332

Vancouver

Khashami F, Dimitrov IE, Fuetterer M, Glöggler S, Zhang B, Tan E, et al. Optimized Detection of Left Ventricular Hyperpolarized [1‐ 13 C]Pyruvate Signal in Human Cardiac Metabolic Imaging. Magnetic Resonance in Medicine. 2026;96(1):420-434. doi:10.1002/mrm.70332

BibTeX
@article{Khashami2026,
  author = {Khashami, Fatemeh and Dimitrov, Ivan E and Fuetterer, Maximilian and Glöggler, Stefan and Zhang, Bei and Tan, Egzona and Kozerke, Sebastian and Henning, Anke and Hussain, Tarique and Malloy, Craig R and Unni, Nisha and Zaha, Vlad G and CTOX Trial Investigator(s), CTOX Trial Investigator(s)},
  title = {Optimized Detection of Left Ventricular Hyperpolarized [1‐ 13 C]Pyruvate Signal in Human Cardiac Metabolic Imaging},
  journal = {Magnetic Resonance in Medicine},
  year = {2026},
  volume = {96},
  number = {1},
  pages = {420--434},
  doi = {10.1002/mrm.70332}
}
Kostenlos starten →